Patient basic information Patient: Ms. Tatiana King Nationality: Mauritania Disease Diagnosis: Melanoma Diagnostic Hospital: University of Ningbo Affiliated First Hospital Treatment Program: Blood Stem Transplant + Chemotherapy Accommodation: 67 days Treatment cost: about 841272 yuan Treatment effect: partial relief The patient is from Mauritania, where she was diagnosed with melanoma. Upon arrival at the First Hospital of the University of Ningbo, the International Medical Services team arranged for the first time multidisciplinary MDT sessions for patients, developed individualized pathways based on the patient's examination reports and physical condition, and provided translation, accompaniment and landing services throughout the treatment process.
After 67 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached the hospital standard. The treatment effect was a partial relief. When the patient was discharged, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to monitor the recovery through the remote follow-up system.
The patient commented, 'The level of expertise of Chinese doctors and the condition of the equipment in Chinese hospitals impressed us, and every link from the ground to the hospital was well arranged. 'Mrs. Tatiana, expert comment on this case as a typical case of cross-border suspected seriousness clinical cases.
The first hospital affiliated to the University of Ningbo, based on a multidisciplinary collaborative mechanism, developed a blood stem cell transplant + chemotherapy program for melanoma, which reflects the integrated strength of Chinese hospitals in the field of suspected disease diagnosis and is a shortened version of how international medical services are regulated. (This image is taken from the official news report and medical scene of the first hospital affiliated to the University of Ningbo)